Weekly News Roundup – Neuro Breakthroughs, Biosimilar Reform, and an Obesity Drug Showdown
Update: 2025-10-31
Description
This week’s tHEORetically Speaking News Roundup covers Evotec and Bristol Myers Squibb’s progress in developing next-generation therapies for neurodegenerative diseases, the FDA’s game-changing move to streamline biosimilar approvals and lower drug costs, and Novo Nordisk’s bold $6.5B counteroffer to outbid Pfizer for Metsera in the obesity treatment race.
Tune in for this concise recap of the top stories shaping HEOR, RWE, and Market Access this week.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
